Andrew Huberman· PhD
so we ended up with 17 kids that were on active drug and 13 that were on Placebo
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
so we ended up with 17 kids that were on active drug and 13 that were on Placebo
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
yes in a small study but you're now extending this to a larger cohort as you mentioned uh a causal relationship when B oppress is administered to these low vasopress SL low social functioning kids their symptoms improve
and so you know we do have anecdotal reports like that and I think you know the tricky part is are we we didn't stratify anyone going into this trial right and so the concern always is did we get really lucky in the first trial and we somehow got the the quote unquote right people that entered the trial that we're going to be the ones who would respond to the medication or is this a medication that has sort of broad use in this population and we you know the second trial will be um positive you used nasal spray to deliver the vasopress and and um presumably that gets into the blood circulation of the brain